发明名称 MODIFIED PEPTIDE AS THERAPEUTIC MEDICINE
摘要 PROBLEM TO BE SOLVED: To provide fusion of Fc domains with biologically active peptides and pharmaceutical agents and compositions using biologically active peptides. SOLUTION: Pharmacologically active compounds are prepared by a process comprising: (a) selecting at least one peptide that modulates the activity of a protein of interest; and (b) preparing a pharmacologic agent comprising an Fc domain covalently linked to at least one amino acid of the selected peptide. Linkage to the vehicle increases the half-life of the peptide, which otherwise would be quickly degraded in vivo. The preferred vehicle is an Fc domain. The peptide is preferably selected by phage display, E. coli display, RNA-peptide screening, or chemical-peptide screening. COPYRIGHT: (C)2007,JPO&INPIT
申请公布号 JP2007084555(A) 申请公布日期 2007.04.05
申请号 JP20060288325 申请日期 2006.10.24
申请人 AMGEN 发明人 FEIGE ULRICH;LIU CHUAN-FA;CHEETHAM JANET;BOONE THOMAS CHARLES
分类号 C07K19/00;G01N33/50;A61K38/00;A61P3/04;A61P7/06;A61P19/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P37/02;A61P43/00;C07K;C07K14/47;C07K14/505;C07K14/52;C07K14/525;C07K14/545;C07K16/00;C07K16/18;C12N;C12N1/21;C12N9/64;C12N15/09;C12N15/62;C12N15/70;C12P21/02;C12R1/19;G01N33/15;G01N33/566 主分类号 C07K19/00
代理机构 代理人
主权项
地址